London · Delayed Price · Currency is GBP · Price in GBX Futura Medical Statistics
Total Valuation
Futura Medical has a market cap or net worth of GBP 3.20 million. The enterprise value is -204,328.
| Market Cap | 3.20M |
| Enterprise Value | -204,328 |
Important Dates
The next estimated earnings date is Wednesday, June 17, 2026.
| Earnings Date | Jun 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Futura Medical has 581.33 million shares outstanding. The number of shares has increased by 4.89% in one year.
| Current Share Class | 581.33M |
| Shares Outstanding | 581.33M |
| Shares Change (YoY) | +4.89% |
| Shares Change (QoQ) | +14.58% |
| Owned by Insiders (%) | 7.98% |
| Owned by Institutions (%) | 80.71% |
| Float | 513.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.88 |
| PB Ratio | 1.14 |
| P/TBV Ratio | 1.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.06
| Current Ratio | 2.06 |
| Quick Ratio | 1.86 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -154.16% and return on invested capital (ROIC) is -96.75%.
| Return on Equity (ROE) | -154.16% |
| Return on Assets (ROA) | -60.53% |
| Return on Invested Capital (ROIC) | -96.75% |
| Return on Capital Employed (ROCE) | -298.65% |
| Weighted Average Cost of Capital (WACC) | 4.36% |
| Revenue Per Employee | 130,512 |
| Profits Per Employee | -697,746 |
| Employee Count | 14 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 2.00 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.80% in the last 52 weeks. The beta is 0.02, so Futura Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.02 |
| 52-Week Price Change | -92.80% |
| 50-Day Moving Average | 0.87 |
| 200-Day Moving Average | 2.02 |
| Relative Strength Index (RSI) | 46.26 |
| Average Volume (20 Days) | 4,150,137 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Futura Medical had revenue of GBP 1.70 million and -9.07 million in losses. Loss per share was -0.03.
| Revenue | 1.70M |
| Gross Profit | 1.24M |
| Operating Income | -9.11M |
| Pretax Income | -9.07M |
| Net Income | -9.07M |
| EBITDA | -8.99M |
| EBIT | -9.11M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 3.40 million in cash and n/a in debt, with a net cash position of 3.40 million or 0.01 per share.
| Cash & Cash Equivalents | 3.40M |
| Total Debt | n/a |
| Net Cash | 3.40M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 2.81M |
| Book Value Per Share | 0.00 |
| Working Capital | 2.30M |
Cash Flow
| Operating Cash Flow | -5.62M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 121,991 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 73.08% |
| Operating Margin | -536.87% |
| Pretax Margin | -534.62% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Futura Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.89% |
| Shareholder Yield | -4.89% |
| Earnings Yield | -283.70% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Futura Medical has an Altman Z-Score of -16.92 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -16.92 |
| Piotroski F-Score | 2 |